Elizabeth McKenna (@elizsmckenna) 's Twitter Profile
Elizabeth McKenna

@elizsmckenna

Executive Editor of Cancer Discovery @CD_AACR, published by @AACR. @BBS_Harvard/@DanaFarber alum. Native New Yorker. Views/likes/RTs are my own. She/her

ID: 24753832

linkhttps://aacrjournals.org/cancerdiscovery calendar_today16-03-2009 19:42:02

13,13K Tweet

16,16K Followers

5,5K Following

Pat Adams (@pathologypat) 's Twitter Profile Photo

T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study | Cancer Discovery | American Association for Cancer Research aacrjournals.org/cancerdiscover…

Neta Erez- ErezLab🎗️ (@erezneta) 's Twitter Profile Photo

Thank you EACR for highlighting our work on breast cancer bone metastasis! New immunotherapy combinations are the way to combat #metastasis. Lea Monteran Cancer Discovery magazine.eacr.org/highlights-in-…

Thank you <a href="/EACRnews/">EACR</a> for highlighting our work on breast cancer bone metastasis!
New immunotherapy combinations are the way to combat #metastasis.
<a href="/LMonteran/">Lea Monteran</a> <a href="/CD_AACR/">Cancer Discovery</a> 
magazine.eacr.org/highlights-in-…
Leo Meriranta (@merijellona) 's Twitter Profile Photo

Editorial by Müschen Lab Coraline Mlynarczyk and colleagues in Cancer Discovery puts together the results from these studies with emphasis on druggability 💊Highlights on how they align with Pola-V benefit seen mostly in ABC/MCD DLBCL and how KLHL6 could be targeted to sensitize others

Editorial by <a href="/MuschenLab/">Müschen Lab</a> <a href="/coraline_mly/">Coraline Mlynarczyk</a> and colleagues in <a href="/CD_AACR/">Cancer Discovery</a>  puts together the results from these studies with emphasis on druggability

💊Highlights on how they align with Pola-V benefit seen mostly in ABC/MCD DLBCL and how KLHL6 could be targeted to sensitize others
AACR (@aacr) 's Twitter Profile Photo

August Editors’ Picks from the 10 AACR journals include a “colon-age” metric for personalizing colorectal cancer screening, a look at how violent environments affect stress signaling in lung tumors, and more. Learn more on the #AACRBlog: bit.ly/3XsWRge

August Editors’ Picks from the 10 AACR journals include a “colon-age” metric for personalizing colorectal cancer screening, a look at how violent environments affect stress signaling in lung tumors, and more. Learn more on the #AACRBlog: bit.ly/3XsWRge
Cancer Discovery (@cd_aacr) 's Twitter Profile Photo

Read the article: Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity. bit.ly/3Xu17fe

Cancer Discovery (@cd_aacr) 's Twitter Profile Photo

Phosphocreatine Promotes Epigenetic Reprogramming to Facilitate #Glioblastoma Growth through Stabilizing BRD2, Lishu Chen, Qinghui Qi, Xiaoqing Jiang, Jin Wu, Tao Zhou, Jianghong Man, et al. bit.ly/3zh7CZz #NanhuLaboratory #NationalCenterofBiomedicalAnalysis.

Phosphocreatine Promotes Epigenetic Reprogramming to Facilitate #Glioblastoma Growth through Stabilizing BRD2, Lishu Chen, Qinghui Qi, Xiaoqing Jiang, Jin Wu, Tao Zhou, Jianghong Man, et al. bit.ly/3zh7CZz #NanhuLaboratory #NationalCenterofBiomedicalAnalysis.
Jitendra K Meena (@jitendrakmeena) 's Twitter Profile Photo

I'm super excited to see our work featured on the cover art of the September issue of Cancer Discovery Cancer Discovery. aacrjournals.org/cancerdiscover… Artwork by Bianca Dunn

I'm super excited to see our work featured on the cover art of the September issue of Cancer Discovery <a href="/CD_AACR/">Cancer Discovery</a>. aacrjournals.org/cancerdiscover… Artwork by Bianca Dunn
Elizabeth McKenna (@elizsmckenna) 's Twitter Profile Photo

The September issue of Cancer Discovery is now online! The cover features work by by Jitendra K Meena, Westbrook Lab and colleagues showing MYC induces oncogenic stress through RNA decay and ribonucleotide catabolism. That and much more here: aacrjournals.org/cancerdiscover…

Claire E Thomas (@claire_ethomas) 's Twitter Profile Photo

AACR NextGen Star Future Directions commentary is out! Thank you to the AACR for this fantastic opportunity to write about integration of immune profiling into epidemiologic studies #epitwitter aacrjournals.org/cancerdiscover…

Jonathan A. Nowak (@jonathan_nowak) 's Twitter Profile Photo

Congrats on your award NextGen ⭐️award Claire! Exciting to have our collaborative work on CRC epidemiology, molecular features, and the immune microenvironment highlighted in Cancer Discovery.

Santi Demajo Meseguer (@santidemajo) 's Twitter Profile Photo

‼️ The final version of our article “Identification of Clonal Hematopoiesis Driver Mutations through In Silico Saturation Mutagenesis” is out in Cancer Discovery Cancer Discovery: aacrjournals.org/cancerdiscover… Learn more about our findings in this thread 👇🏽

‼️ The final version of our article “Identification of Clonal Hematopoiesis Driver Mutations through In Silico Saturation Mutagenesis” is out in Cancer Discovery <a href="/CD_AACR/">Cancer Discovery</a>: aacrjournals.org/cancerdiscover…

Learn more about our findings in this thread 👇🏽
Nuria Lopez-Bigas (@nlbigas) 's Twitter Profile Photo

Our latest paper -> On identifying the mutations driving clonal hematopoiesis using machine learning models - BoostDM-CH Great team work by Santi Demajo Meseguer, Joan Enric Ramis Z, Ferran Muiños et al Tweetorial 👇

Nuria Lopez-Bigas (@nlbigas) 's Twitter Profile Photo

Check also the Views paper on our work written by Christopher Arends and Siddhartha Jaiswal Thanks for the accurate summary and perspective on our work Siddhartha Jaiswal aacrjournals.org/cancerdiscover…

Check also the Views paper on our work written by Christopher Arends and Siddhartha Jaiswal 

Thanks for the accurate summary and perspective on our work <a href="/jaiswalmdphd/">Siddhartha Jaiswal</a>

aacrjournals.org/cancerdiscover…
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in mBRAF Cancers Using Pharmacokinetics-Informed Dose Escalation Cancer Discovery doi.org/10.1158/2159-8… 👏efficient dose escalation concept 👉compelling activity in resistent pts 🤩great to see the new generation

A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in mBRAF Cancers Using Pharmacokinetics-Informed Dose Escalation
<a href="/CD_AACR/">Cancer Discovery</a> 
doi.org/10.1158/2159-8…
👏efficient dose escalation concept
👉compelling activity in resistent pts
🤩great to see the new generation